These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18091493)

  • 1. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis.
    Allen RT; Lee YP; Stimson E; Garfin SR
    Spine (Phila Pa 1976); 2007 Dec; 32(26):2996-3006. PubMed ID: 18091493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-stage treatment of pyogenic spinal infection with titanium mesh cages.
    Kuklo TR; Potter BK; Bell RS; Moquin RR; Rosner MK
    J Spinal Disord Tech; 2006 Jul; 19(5):376-82. PubMed ID: 16826013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.
    O'Shaughnessy BA; Kuklo TR; Ondra SL
    Spine (Phila Pa 1976); 2008 Mar; 33(5):E132-9. PubMed ID: 18317180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corpectomy followed by the placement of instrumentation with titanium cages and recombinant human bone morphogenetic protein-2 for vertebral osteomyelitis.
    Aryan HE; Lu DC; Acosta FL; Ames CP
    J Neurosurg Spine; 2007 Jan; 6(1):23-30. PubMed ID: 17233287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
    Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Debridement and Interbody Graft Using Titanium Mesh Cage, Posterior Monosegmental Instrumentation, and Fusion in the Surgical Treatment of Monosegmental Lumbar or Lumbosacral Pyogenic Vertebral Osteomyelitis via a Posterior-Only Approach.
    Zhang HQ; Wang YX; Wu JH; Chen J
    World Neurosurg; 2020 Mar; 135():e116-e125. PubMed ID: 31756509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vertebral osteomyelitis by radical debridement and stabilization using titanium mesh cages.
    Ruf M; Stoltze D; Merk HR; Ames M; Harms J
    Spine (Phila Pa 1976); 2007 Apr; 32(9):E275-80. PubMed ID: 17450059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate.
    Baskin DS; Ryan P; Sonntag V; Westmark R; Widmayer MA
    Spine (Phila Pa 1976); 2003 Jun; 28(12):1219-24; discussion 1225. PubMed ID: 12811263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prevertebral soft-tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis.
    Stachniak JB; Diebner JD; Brunk ES; Speed SM
    J Neurosurg Spine; 2011 Feb; 14(2):244-9. PubMed ID: 21184639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
    Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
    Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
    Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior-only debridement, bone fusion, single-segment versus short-segment instrumentation for mono-segmental lumbar or lumbosacral pyogenic vertebral osteomyelitis: minimum five year follow-up outcomes.
    Zhang HQ; Wang YX; Guo CF; Tang MX; Liu SH; Deng A; Gao Q
    J Orthop Surg Res; 2022 Aug; 17(1):388. PubMed ID: 35962360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
    Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.